医学
社会心理的
纵向研究
2型糖尿病
糖尿病
药物依从性
年轻人
1型糖尿病
老年学
临床心理学
精神科
内科学
内分泌学
病理
作者
Paula M. Trief,Diane Uschner,Seth C. Kalichman,Barbara J. Anderson,Lida M. Fette,Hui Wen,Jane Bulger,Ruth S. Weinstock
摘要
Abstract Aim To identify psychosocial predictors of medication adherence in young adults with youth‐onset type 2 diabetes in the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY2) cohort. Methods Participants (mean age: 26 years) completed validated psychosocial measures. Unannounced telephone pill counts were completed at T1 (baseline) and T2 (follow‐up, approximately 1 year later) to assess adherence to oral hypoglycaemia agents (OHAs). Adherence to insulin was assessed by self‐report. Logistic and linear regressions identified factors that predicted ‘low adherence’ (<80% of pills/insulin) and per cent adherence, adjusted for potential confounders. Results Of 171 participants with OHA adherence scores at T1 and T2 (65% women, 43% Hispanic and 35% non‐Hispanic Black), 65.4% were low adherent. After adjustment (including T1 adherence), concerns about diabetes medicines (adverse effects, dependence) at T1 predicted higher odds of being low adherent (categorical) at T2 ( p = 0.019). Housing insecurity ( p = 0.045) and reporting ≥2 need insecurities ( p = 0.027) at T1 predicted lower per cent adherence (continuous) at T2. Of 157 participants with insulin adherence scores at T1 and T2 (69% women, 38% Hispanic and 38% non‐Hispanic Black), 36.3% were low adherent. After adjustment (including T1 adherence), beliefs that medicines are overused predicted higher odds of insulin low adherence at T2 ( p = 0.013), and beliefs that medicines are harmful ( p = 0.004) and overused ( p = 0.010) predicted lower per cent insulin adherence at T2. Conclusions Suboptimal medication adherence, common in young adults with youth‐onset type 2 diabetes, is predicted by interfering beliefs about medicines and social factors. We must address these beliefs and unmet needs to develop tailored interventions for this vulnerable group.
科研通智能强力驱动
Strongly Powered by AbleSci AI